Ultrasound (US) is a very helpful clinical tool in rheumatology due to its low cost, portability, and accessibility for point ...
A 65-year-old white woman presented with 9 months of intermittent “kaleidoscopic” visual disturbances and blurred vision upon ...
Pharmaceutical Technology on MSN
Novartis wins FDA approval for Cosentyx to treat paediatric HS patients
Cosentyx’s IL-17A mechanism provides a differentiated approach for HS in younger patients.
Paracentral acute middle maculopathy is a highly specific OCT marker for biopsy-proven giant cell arteritis with ocular ischemic involvement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results